Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
03/2010
03/30/2010CA2162150C Germline mutations in the mts gene and method for detecting predisposition to cancer at the mts gene
03/30/2010CA2155004C Stable bactericidal/permeability-increasing protein products and pharmaceutical compositions containing the same
03/25/2010WO2010033991A2 Detection of human somatic cell reprogramming
03/25/2010WO2010033969A1 Amniotic-fluid-derived pluripotent cells
03/25/2010WO2010033949A1 Methods and compositions for generating an immune response by inducing cd40 and pattern recognition receptor adapters
03/25/2010WO2010033925A2 Peptide-presenting surfaces for long-term culture of pluripotent cells
03/25/2010WO2010033906A2 Efficient induction of pluripotent stem cells using small molecule compounds
03/25/2010WO2010033722A2 Construction of fully-deleted adenovirus-based gene delivery vectors and uses thereof
03/25/2010WO2010033617A2 Stapled peptides and method of synthesis
03/25/2010WO2010033605A2 Compositions containing platelet contents
03/25/2010WO2010033564A1 Transgenic plants having increased biomass
03/25/2010WO2010033138A1 Growth factor supplement for stem cell cultures
03/25/2010WO2010033088A2 Method of improving differentiation of chondrogenic progenitor cells
03/25/2010WO2010033085A1 Chinese hamster ovary cell lines
03/25/2010WO2010033084A1 Markers of induced pluripotent stem cells
03/25/2010WO2010032786A1 Transgenic animal
03/25/2010WO2010032696A1 Diagnosis method and therapeutic method for cancer
03/25/2010WO2010032007A1 Use of ctgf as a cardioprotectant
03/25/2010WO2010031190A1 Culture medium for myoblasts, precursors thereof and derivatives thereof
03/25/2010WO2010007502A3 Platelet fraction deriving from placental blood
03/25/2010WO2009141729A3 Anti-tumoral cells
03/25/2010WO2009136382A3 Antibodies to receptor of advanced glycation end products (rage) and uses thereof
03/25/2010WO2009132083A3 Compositions and methods for promoting the generation of pdx1+ pancreatic cells
03/25/2010WO2006076423A8 Genes and uses for plant improvement
03/25/2010US20100077514 Gene Expression Modulating Element
03/25/2010US20100077510 Plant galactinol synthase homologs
03/25/2010US20100077509 Nucleic acid molecules encoding plant proteins in the c3hc4 family and methods for the alteration of plant cellulose and lignin content
03/25/2010US20100077508 Novel Bacillus Thuringiensis Gene with Lepidopteran Activity
03/25/2010US20100077505 Auxin Transport Proteins
03/25/2010US20100077503 Transferases, Epimerases, Polynucleotides Encoding These and Uses Thereof
03/25/2010US20100077501 Insect resistant cotton plants and methods for identifying same
03/25/2010US20100077497 Ip-10 antibodies and their uses
03/25/2010US20100077496 MO-1, A Gene Associated With Morbid Obesity
03/25/2010US20100077495 Compositions and methods for the expression of nucleic acids
03/25/2010US20100077490 Animal model exhibiting cancer, pulmonary emphysema and cardiomyopathy
03/25/2010US20100076380 Bioreactors
03/25/2010US20100076060 Aptamers as agonists
03/25/2010US20100076054 Sensizitation of cancer cells to therapy using sina targeting genes from the 1p and 19q chromosomal regions
03/25/2010US20100076018 Compounds and Methods for Treatment of Alpha-1 Antitrypsin Deficiency
03/25/2010US20100076010 Alpha 1a-adrenoceptor antagonists
03/25/2010US20100075920 Small molecule stimulators of neuronal growth
03/25/2010US20100075915 Methods for cancer therapy and stem cell modulation
03/25/2010US20100075911 Dimeric iap inhibitors
03/25/2010US20100075905 Novel cellular factor-containing solution compositions
03/25/2010US20100075899 Targeted photodynamic therapy agent
03/25/2010US20100075898 N-terminal vdac variants and uses thereof
03/25/2010US20100075892 Inhibition of SKP2-Cyclin a Interaction
03/25/2010US20100075891 Novel polynucleotides encoding polypeptides and methods using same
03/25/2010US20100075423 Methods and compositions relating to polypeptides with rnase iii domains that mediate rna interference
03/25/2010US20100075421 Efficient method for nuclear reprogramming
03/25/2010US20100075420 Novel Gene Delivery Vectors for Human Mesenchymal Stem Cells
03/25/2010US20100075419 Biomaterial, method of constructing the same and use thereof
03/25/2010US20100075418 Method for co-culture of stem cells and feeder cells using polymer membrane
03/25/2010US20100075417 Methods and devices for isolating embryonic stem cells
03/25/2010US20100075416 Growth Factor Supplement for Stem Cell Cultures
03/25/2010US20100075415 Method for reducing protease activity in plant hydrolysate
03/25/2010US20100075414 Growth of foreign cells after conditional and selective destruction of fetal host cells
03/25/2010US20100075413 Improved process for the culturing of cells
03/25/2010US20100075412 T1r taste receptors and genes encoding same
03/25/2010US20100075402 DNA coding for polypeptide fusion
03/25/2010US20100075380 Novel Lipase
03/25/2010US20100075378 Moraxella catarrhalis basb115 polypeptides
03/25/2010US20100075366 Methods for identifying stem cells by detecting fluorescence of cells and syncytia
03/25/2010US20100075343 Novel peptides
03/25/2010US20100075295 Novel Cellular Compositions and Methods for Their Preparation
03/25/2010US20100075294 Novel Cellular Compositions and Methods for Their Preparation
03/25/2010US20100074995 Poplar transcription factors
03/25/2010US20100074956 Formation of hydrogel in the presence of peroxidase and low concentration of hydrogen peroxide
03/25/2010US20100074945 Mutated ras peptides for generation of cd8+ cytotoxic t lymphocytes
03/25/2010US20100074925 Antigen specific multi epitope vaccines
03/25/2010US20100074919 Circovirus sequences associated with piglet weight loss disease (PWD)
03/25/2010US20100074912 Hila-a24-binding kef-derived peptide
03/25/2010US20100074907 Methods for Promoting Myelination, Neuronal Survival and Oligodendrocyte Differentiation Via Administration of SP35 or TrkA Antagonists
03/25/2010US20100074906 Antibodies Specific for Varicella Zoster Virus
03/25/2010US20100074905 Methods for soluble zalpha11 cytokine receptors
03/25/2010US20100074901 Human anti-amyloid antibodies, compositions, methods and uses
03/25/2010US20100074900 Prostaglandin e2 dual variable domain immunoglobulins and uses thereof
03/25/2010US20100074893 ECM-Complex Antibody Compositions and Methods of Use
03/25/2010US20100074892 Monoclonal Antibodies That Neutralize Anthrax Protective Antigen (PA) Toxin
03/25/2010US20100074875 Composition containing human umbilical cord blood-derived mesenchymal stem cell for inducing differentiation and proliferation of neural precursor cells or neural stem cells to neural cells
03/25/2010US20100074874 Synthetic multi-layer structures comprising biopolymer fibres
03/25/2010US20100074869 Multifunctional Cytokines
03/25/2010US20100074852 Use of cis-epoxyeicosatrienoic acids and inhibitors of soluble epoxide hydrolase to treat conditions mediated by pbr, cb2, and nk2 receptors
03/25/2010US20100074847 Chromophore Probes for Optical Imaging
03/25/2010US20100074841 Compositions Against Cancer Antigen LIV-1 and Uses Thereof
03/25/2010DE69029370C5 Erythropoietin-Isoformen Erythropoietin isoforms
03/25/2010CA2770302A1 Small molecule compounds for stem cell differentiation
03/25/2010CA2739368A1 Markers of induced pluripotent stem cells
03/25/2010CA2739364A1 Peptide-presenting surfaces for long-term culture of pluripotent cells
03/25/2010CA2738031A1 Methods and compositions for generating an immune response by inducing cd40 and pattern recognition receptor adapters
03/25/2010CA2737748A1 Chinese hamster ovary cell lines
03/25/2010CA2737448A1 Use of ctgf as a cardioprotectant
03/25/2010CA2737212A1 Dendritic cell modulatory molecule
03/24/2010EP2166107A1 Lentiviral vectors for the expression of shRNA
03/24/2010EP2166096A2 Moraxella (Branhamella) catarrhalis antigens
03/24/2010EP2166093A1 Pharmaceutical composition for enzyme replacement therapy
03/24/2010EP2166087A2 FAD4, FAD5, FAD5-2 et FAD6, fatty acid desaturase family members and uses thereof
03/24/2010EP2166086A2 Plants having improved growth characteristics and methods for making the same
03/24/2010EP2166085A1 Divalent modified cells
03/24/2010EP2166084A1 Multipotent progenitor cell derived from adipose tissue